Literature DB >> 11166535

Stability of indicators of the metabolic syndrome from childhood and adolescence to young adulthood: the Québec Family Study.

P T Katzmarzyk1, L Pérusse, R M Malina, J Bergeron, J P Després, C Bouchard.   

Abstract

The stability of indicators of the metabolic syndrome from childhood and adolescence to young adulthood was examined. The sample included 76 males and 71 females measured between the ages of 8 and 18 years and again as young adults (12 year follow-up). Indicators included the sum of three trunk skinfolds (SF3), mean blood pressure (MBP), and fasting blood glucose (GLY), high-density lipoprotein cholesterol (HDL-C), ratio of total cholesterol to HDL-C (CHOL/HDL), and triglycerides (TG). The indicators were subjected to principal components analysis to obtain a composite risk factor index (RFI). Partial interage correlations, controlling for initial age and length of follow-up, were 0.70 and 0.50 for SF3, 0.40 and 0.54 for MBP, 0.58 and 0.56 for HDL-C, 0.51 and 0.57 for CHOL/HDL, 0.37 and 0.20 (NS) for TG, 0.30 and 0.14 (NS) for GLY, and 0.51 and 0.46 for the RFI, in males and females, respectively. The results indicate that indicators of the metabolic syndrome are moderately stable from childhood and adolescence into young adulthood.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11166535     DOI: 10.1016/s0895-4356(00)00315-2

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  74 in total

1.  The metabolic syndrome in healthy, multiethnic adolescents in Toronto, Ontario: the use of fasting blood glucose as a simple indicator.

Authors:  Vladimir Vuksan; Valentina Peeva; Alexander Rogovik; Uljana Beljan-Zdravkovic; Mark Stavro; Alexandra Jenkins; Andre G Dias; Sudi Devanesen; John Sievenpiper; Amir Hanna
Journal:  Can J Cardiol       Date:  2010-03       Impact factor: 5.223

2.  Predicting cardiovascular risk in young adulthood from the metabolic syndrome, its component risk factors, and a cluster score in childhood.

Authors:  Aaron S Kelly; Julia Steinberger; David R Jacobs; Ching-Ping Hong; Antoinette Moran; Alan R Sinaiko
Journal:  Int J Pediatr Obes       Date:  2010-11-11

3.  Strength capacity and cardiometabolic risk clustering in adolescents.

Authors:  Mark D Peterson; William A Saltarelli; Paul S Visich; Paul M Gordon
Journal:  Pediatrics       Date:  2014-03-31       Impact factor: 7.124

4.  Anthropometric measurements for the prediction of the metabolic syndrome: a cross-sectional study on adolescents and young adults from southern india.

Authors:  S K Vasan; N Thomas; S Christopher; F S Geethanjali; T V Paul; C B Sanjeevi
Journal:  Heart Asia       Date:  2011-01-01

5.  Prevalence of metabolic syndrome and associated cardiovascular risk factors in Guatemalan school children.

Authors:  Omar Mbowe; Alicia Diaz; Jana Wallace; Manolo Mazariegos; Pauline Jolly
Journal:  Matern Child Health J       Date:  2014-09

Review 6.  Cardiovascular and Metabolic Complications - Diagnosis and Management in Obese Children.

Authors:  Naval K Vikram
Journal:  Indian J Pediatr       Date:  2017-12-08       Impact factor: 1.967

7.  Examining metabolic syndrome definitions in overweight Hispanic youth: a focus on insulin resistance.

Authors:  Gabriel Q Shaibi; Michael I Goran
Journal:  J Pediatr       Date:  2007-10-22       Impact factor: 4.406

8.  The stability of metabolic syndrome in children and adolescents.

Authors:  Jennifer K Gustafson; Lisa B Yanoff; Benjamin D Easter; Sheila M Brady; Margaret F Keil; Mary D Roberts; Nancy G Sebring; Joan C Han; Susan Z Yanovski; Van S Hubbard; Jack A Yanovski
Journal:  J Clin Endocrinol Metab       Date:  2009-10-16       Impact factor: 5.958

9.  Construct validity of a continuous metabolic syndrome score in children.

Authors:  Joey C Eisenmann; Kelly R Laurson; Katrina D DuBose; Bryan K Smith; Joseph E Donnelly
Journal:  Diabetol Metab Syndr       Date:  2010-01-28       Impact factor: 3.320

10.  Cardiorespiratory fitness predicts clustered cardiometabolic risk in 10-11.9-year-olds.

Authors:  Emma L Houston; Julien S Baker; Duncan S Buchan; Gareth Stratton; Stuart J Fairclough; Lawrence Foweather; Rebecca Gobbi; Lee E F Graves; Nicola Hopkins; Lynne M Boddy
Journal:  Eur J Pediatr       Date:  2013-02-26       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.